Favipiravir: A Possible Pharmaceutical Treatment for COVID-19
Hidekatsu Yanai
Topics & Concepts
MedicineFavipiravirCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicIntensive care medicineVirologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsSARS-CoV-2 and COVID-19 Research